Internal Medicine, Interventional Cardiology · Shenandoah, TX
NPI
1811959125
Since 2006
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
17183 I H 45 S Ste 640
Shenandoah, TX, 77385
Phone (936) 270-3933
Groups this clinician bills Medicare through
Medicare paid, 2024
$440K
5,200 services
Medicare patients, 2024
1,189
Average age 75
Drug cost, 2024
$2.1M
11,129 prescriptions
Company payments, 2025
$2,048
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ali N Rizvi was code J2785 (injection, regadenoson, 0.1 mg), 1,140 times for 284 patients. In total Ali N Rizvi billed 5,200 services in 81 codes, and Medicare paid $440K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-09-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2785 Injection, regadenoson, 0.1 mg | Office | 1,140 | 284 | $5.56 | $6,340 |
| 99214 Office E&M - Established | Office | 937 | 831 | $82.09 | $77K |
| 93306 Echocardiography (TTE/TEE) | Office | 462 | 455 | $125.71 | $58K |
| 93015 Electrocardiogram | Office | 388 | 385 | $46.68 | $18K |
| 78452 Myocardial Perfusion Scan | Office | 378 | 376 | $309.95 | $117K |
| 99204 Office E&M - New | Office | 218 | 218 | $108.21 | $24K |
| 99233 Hospital E&M - Subsequent | Facility | 171 | 90 | $86.27 | $15K |
| 99152 Anesthesia | Facility | 168 | 141 | $9.16 | $1,540 |
| 93458 Percutaneous Transcatheterization | Facility | 108 | 108 | $175.59 | $19K |
| 93000 Electrocardiogram | Office | 85 | 77 | $9.48 | $806 |
| 93306 Echocardiography (TTE/TEE) | Facility | 84 | 84 | $49.27 | $4,139 |
| 93325 Echocardiography (TTE/TEE) | Facility | 72 | 58 | $2.31 | $166 |
| 99221 Hospital E&M - Initial | Facility | 70 | 66 | $57.81 | $4,046 |
| 92978 Echocardiography (TTE/TEE) | Facility | 63 | 49 | $70.42 | $4,437 |
| 92928 Percutaneous Coronary Artery Angioplasty and Stenting | Facility | 61 | 47 | $414.06 | $25K |
By year: 2022 $407K for 4,425 services; 2023 $433K for 5,192 services; 2024 $440K for 5,200 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ali N Rizvi prescribed most often to Medicare patients was Metoprolol Succinate, with 1,597 prescriptions and refills. In total Ali N Rizvi wrote 11,129 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,597 | 4,219 | 518 | $22K |
| Atorvastatin Calcium Generic | 1,594 | 4,494 | 517 | $18K |
| Eliquis Apixaban | 888 | 1,668 | 210 | $940K |
| Valsartan Generic | 778 | 2,087 | 250 | $22K |
| Rosuvastatin Calcium Generic | 606 | 1,606 | 190 | $8,350 |
| Clopidogrel Clopidogrel Bisulfate | 513 | 1,374 | 168 | $5,944 |
| Amlodipine Besylate Generic | 487 | 1,276 | 166 | $2,928 |
| Repatha Sureclick Evolocumab | 317 | 632 | 90 | $352K |
| Nifedipine Er Nifedipine | 279 | 735 | 97 | $9,253 |
| Metoprolol Tartrate Generic | 256 | 721 | 88 | $2,392 |
| Lisinopril Generic | 256 | 710 | 88 | $1,829 |
| Valsartan-Hydrochlorothiazide Valsartan/Hydrochlorothiazide | 246 | 638 | 77 | $8,390 |
| Brilinta Ticagrelor | 246 | 391 | 73 | $168K |
| Furosemide Generic | 245 | 617 | 91 | $1,133 |
| Ezetimibe Generic | 243 | 682 | 87 | $7,739 |
Brand drugs: 1,954 claims; generic drugs: 9,175 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ali N Rizvi $2,048 ($2,048 in general payments such as food, travel and fees) from 15 companies. The largest payer was Medtronic, Inc. with $977.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 21 | $977 |
| Abbott Laboratories ABT | 5 | $271 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $148 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $97.91 |
| Boston Scientific Corporation BSX | 3 | $97.39 |
| Shockwave Medical, Inc JNJ | 2 | $79.64 |
| Actelion Pharmaceuticals US, Inc. JNJ | 2 | $63.94 |
| Heartflow, Inc. HTFL | 1 | $57.98 |
| Endologix LLC | 1 | $55.45 |
| Smith+Nephew, Inc. SNN | 2 | $51.49 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.